$EQBK

Reber Brett A sold $81K of EQBK

Reber Brett A (General Counsel) sold 1,686 shares of EQUITY BANCSHARES INC (EQBK) at $47.85 on 2026-06-11.

Original reporting
SEC EDGAR · Reber Brett A
Published Jun 11, 2026, 8:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EQBK
Neutral
high confidence
Mentioned
$EQBK
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EQBKNeutralLow
01

Why it matters

Provides a fresh, primary-source datapoint on officer selling activity; does not disclose any new company performance, guidance, or legal/regulatory developments.

02

Market read

Traders may note insider selling, but the transaction size and lack of fundamental catalysts suggest limited trading edge.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context, signal-to-noise is low.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-11 (transaction dated 2026-06-11)

Background

The article is an SEC Form 4 insider transaction disclosure for Equity Bancshares Inc.

Company-level read

Ticker impact

$EQBKNeutralHigh confidence
Context

Form 4 shows EQBK general counsel Reber Brett A sold 1,686 shares in an open-market transaction on 2026-06-11 for ~$80.7K.

Expected impact

Low likelihood of a sustained price move driven solely by this disclosure.

Evidence & confidence

The filing is a small, open-market sale by an officer with no 10b5-1 plan stated; it does not include new fundamentals, guidance, or regulatory/contract events.

Market effects

Minimal—single-bank insider transaction does not materially change sector risk or outlook.

Minimal—no geographic or macro linkage beyond the issuer’s own ownership change.

Minimal—no cross-border or systemic signal in the disclosure.

Counterpoint

If the sale is not under a 10b5-1 plan (noted as “No”), some traders may interpret it as near-term caution, but the disclosed size is modest.

Key entities

  • Equity Bancshares Inc

    Subject of the Form 4 insider transaction disclosure.

  • Reber Brett A

    General Counsel who sold 1,686 shares on 2026-06-11.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.